DACOMITINIB vs DALBAVANCIN: Which Drug Is Safer?
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
DACOMITINIB vs DALBAVANCIN: Safety Overview
| Metric | DACOMITINIB | DALBAVANCIN |
|---|---|---|
| Total FAERS Reports | 682 | 1,107 |
| Deaths Reported | 325 | 54 |
| Death Rate | 47.7% | 4.9% |
| Hospitalizations | 168 | 288 |
| Average Patient Age | 64.0 yrs | 61.0 yrs |
| % Female Patients | 52.0% | 46.7% |
| FDA Approval Date | Sep 27, 2018 | May 23, 2014 |
| Manufacturer | Pfizer Laboratories Div Pfizer Inc | Fresenius Kabi USA, LLC |
| Route | ORAL | INTRAVENOUS |
| Marketing Status | Prescription | Prescription |